March 25, 2013
Actavis Inc. and Egis Pharmaceuticals PLC have reached an agreement with AstraZeneca UK Ltd. and Shionogi & Co. Ltd. to end Delaware patent litigation over a planned generic version of blockbuster cholesterol-reducing drug Crestor, the companies announced Monday.